The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transplant Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The demand of transplant diagnostics is increasing repuily.
The global Transplant Diagnostics market size is expected to reach US$ 5609 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Transplant Diagnostics in various end use industries. The expanding demands from the Independent Reference Laboratories, Hospitals & Transplant Centers and Research Laboratories & Academic Institutes,, are propelling Transplant Diagnostics market. Solid Organ Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stem Cell Transplantation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transplant Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transplant Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transplant Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transplant Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transplant Diagnostics covered in this report include BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic and Illumina, etc.
The global Transplant Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Biofortuna
Biomérieux SA
Bio-Rad Laboratories
Caredx
F. Hoffman-La Roche
Gendx
Hologic
Illumina
Immucor
Luminex
Merck KGaA
Omixon
Qiagen
Thermo Fisher Scientific
Global Transplant Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transplant Diagnostics market, Segment by Type:
Solid Organ Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation
Global Transplant Diagnostics market, by Application
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transplant Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The demand of transplant diagnostics is increasing repuily.
The global Transplant Diagnostics market size is expected to reach US$ 5609 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Transplant Diagnostics in various end use industries. The expanding demands from the Independent Reference Laboratories, Hospitals & Transplant Centers and Research Laboratories & Academic Institutes,, are propelling Transplant Diagnostics market. Solid Organ Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stem Cell Transplantation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transplant Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transplant Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transplant Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transplant Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transplant Diagnostics covered in this report include BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic and Illumina, etc.
The global Transplant Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Biofortuna
Biomérieux SA
Bio-Rad Laboratories
Caredx
F. Hoffman-La Roche
Gendx
Hologic
Illumina
Immucor
Luminex
Merck KGaA
Omixon
Qiagen
Thermo Fisher Scientific
Global Transplant Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transplant Diagnostics market, Segment by Type:
Solid Organ Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation
Global Transplant Diagnostics market, by Application
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transplant Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transplant Diagnostics
1.1 Transplant Diagnostics Market Overview
1.1.1 Transplant Diagnostics Product Scope
1.1.2 Transplant Diagnostics Market Status and Outlook
1.2 Global Transplant Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transplant Diagnostics Market Size by Region (2018-2029)
1.4 Global Transplant Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Transplant Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transplant Diagnostics Market Size (2018-2029)
1.6.1 North America Transplant Diagnostics Market Size (2018-2029)
1.6.2 Europe Transplant Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Transplant Diagnostics Market Size (2018-2029)
1.6.4 Latin America Transplant Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Transplant Diagnostics Market Size (2018-2029)
2 Transplant Diagnostics Market by Type
2.1 Introduction
2.1.1 Solid Organ Transplantation
2.1.2 Stem Cell Transplantation
2.1.3 Soft Tissue Transplantation
2.1.4 Bone Marrow Transplantation
2.2 Global Transplant Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transplant Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Transplant Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
3 Transplant Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Independent Reference Laboratories
3.1.2 Hospitals & Transplant Centers
3.1.3 Research Laboratories & Academic Institutes
3.2 Global Transplant Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transplant Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Transplant Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
4 Transplant Diagnostics Competition Analysis by Players
4.1 Global Transplant Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transplant Diagnostics as of 2022)
4.3 Date of Key Players Enter into Transplant Diagnostics Market
4.4 Global Top Players Transplant Diagnostics Headquarters and Area Served
4.5 Key Players Transplant Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Transplant Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BD
5.1.1 BD Profile
5.1.2 BD Main Business
5.1.3 BD Transplant Diagnostics Products, Services and Solutions
5.1.4 BD Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 BD Recent Developments
5.2 Biofortuna
5.2.1 Biofortuna Profile
5.2.2 Biofortuna Main Business
5.2.3 Biofortuna Transplant Diagnostics Products, Services and Solutions
5.2.4 Biofortuna Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Biofortuna Recent Developments
5.3 Biomérieux SA
5.3.1 Biomérieux SA Profile
5.3.2 Biomérieux SA Main Business
5.3.3 Biomérieux SA Transplant Diagnostics Products, Services and Solutions
5.3.4 Biomérieux SA Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories Recent Developments
5.4 Bio-Rad Laboratories
5.4.1 Bio-Rad Laboratories Profile
5.4.2 Bio-Rad Laboratories Main Business
5.4.3 Bio-Rad Laboratories Transplant Diagnostics Products, Services and Solutions
5.4.4 Bio-Rad Laboratories Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories Recent Developments
5.5 Caredx
5.5.1 Caredx Profile
5.5.2 Caredx Main Business
5.5.3 Caredx Transplant Diagnostics Products, Services and Solutions
5.5.4 Caredx Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Caredx Recent Developments
5.6 F. Hoffman-La Roche
5.6.1 F. Hoffman-La Roche Profile
5.6.2 F. Hoffman-La Roche Main Business
5.6.3 F. Hoffman-La Roche Transplant Diagnostics Products, Services and Solutions
5.6.4 F. Hoffman-La Roche Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 F. Hoffman-La Roche Recent Developments
5.7 Gendx
5.7.1 Gendx Profile
5.7.2 Gendx Main Business
5.7.3 Gendx Transplant Diagnostics Products, Services and Solutions
5.7.4 Gendx Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Gendx Recent Developments
5.8 Hologic
5.8.1 Hologic Profile
5.8.2 Hologic Main Business
5.8.3 Hologic Transplant Diagnostics Products, Services and Solutions
5.8.4 Hologic Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic Recent Developments
5.9 Illumina
5.9.1 Illumina Profile
5.9.2 Illumina Main Business
5.9.3 Illumina Transplant Diagnostics Products, Services and Solutions
5.9.4 Illumina Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Illumina Recent Developments
5.10 Immucor
5.10.1 Immucor Profile
5.10.2 Immucor Main Business
5.10.3 Immucor Transplant Diagnostics Products, Services and Solutions
5.10.4 Immucor Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Immucor Recent Developments
5.11 Luminex
5.11.1 Luminex Profile
5.11.2 Luminex Main Business
5.11.3 Luminex Transplant Diagnostics Products, Services and Solutions
5.11.4 Luminex Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Luminex Recent Developments
5.12 Merck KGaA
5.12.1 Merck KGaA Profile
5.12.2 Merck KGaA Main Business
5.12.3 Merck KGaA Transplant Diagnostics Products, Services and Solutions
5.12.4 Merck KGaA Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Merck KGaA Recent Developments
5.13 Omixon
5.13.1 Omixon Profile
5.13.2 Omixon Main Business
5.13.3 Omixon Transplant Diagnostics Products, Services and Solutions
5.13.4 Omixon Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Omixon Recent Developments
5.14 Qiagen
5.14.1 Qiagen Profile
5.14.2 Qiagen Main Business
5.14.3 Qiagen Transplant Diagnostics Products, Services and Solutions
5.14.4 Qiagen Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Qiagen Recent Developments
5.15 Thermo Fisher Scientific
5.15.1 Thermo Fisher Scientific Profile
5.15.2 Thermo Fisher Scientific Main Business
5.15.3 Thermo Fisher Scientific Transplant Diagnostics Products, Services and Solutions
5.15.4 Thermo Fisher Scientific Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Transplant Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transplant Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transplant Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transplant Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transplant Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transplant Diagnostics Market Dynamics
11.1 Transplant Diagnostics Industry Trends
11.2 Transplant Diagnostics Market Drivers
11.3 Transplant Diagnostics Market Challenges
11.4 Transplant Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
